ETAGX
Price
$61.55
Change
-$0.02 (-0.03%)
Updated
Jun 2 closing price
Net Assets
3.23B
PMBJX
Price
$36.06
Change
-$0.20 (-0.55%)
Updated
Jun 2 closing price
Net Assets
24.56B
Interact to see
Advertisement

ETAGX vs PMBJX

Header iconETAGX vs PMBJX Comparison
Open Charts ETAGX vs PMBJXBanner chart's image
ETAGX vs PMBJX Comparison Chart in %
View a ticker or compare two or three
VS
ETAGX vs. PMBJX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETAGX is a Buy and PMBJX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBJX has more cash in the bank: 24.6B vs. ETAGX (3.23B). ETAGX (0.00) and PMBJX (0.00) have matching dividends . ETAGX was incepted earlier than PMBJX: ETAGX (17 years) vs PMBJX (25 years). ETAGX (1.43) is less costly to investors than PMBJX (0.76). ETAGX is a more actively managed with annual turnover of: 60.00 vs. PMBJX (13.70). ETAGX (1000) and PMBJX (1000) have matching initial minimum investment requirements. ETAGX annual gain was more profitable for investors over the last year : 20.42 vs. PMBJX (-13.38). PMBJX return over 5 years is better than : -1.52 vs. ETAGX (-3.21).
ETAGXPMBJXETAGX / PMBJX
Total Expense Ratio1.430.76188%
Annual Report Gross Expense Ratio1.430.76188%
Fund Existence17 years25 years-
Gain YTD13.766-6.906-199%
Front Load6%N/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.23B24.6B13%
Annual Yield % from dividends0.000.00-
Returns for 1 year20.42-13.38-153%
Returns for 3 years35.1115.44227%
Returns for 5 years-3.21-1.52212%
Returns for 10 years154.1176.50201%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CING4.030.43
+11.81%
Cingulate Inc
ATOM9.850.18
+1.86%
Atomera
FITBO18.40-0.12
-0.65%
Fifth Third Bancorp
MANH155.09-6.03
-3.74%
Manhattan Associates
CNXC28.48-1.55
-5.16%
Concentrix Corp